DR. LORENZO DICARLO, MD
Medical Practice at Taylor St, San Francisco, CA
License number
California G41704
Category
Medical Practice
Type
Specialist
Address
Address
1425 Taylor St STE 602, San Francisco, CA 94133
Phone
(415) 806-9000
Personal information
See more information about LORENZO DICARLO at radaris.comName
Address
Phone
1501 S Cerritos Dr, Palm Springs, CA 92264
1602 W 9Th St, San Pedro, CA 90732
331 Dave Dr, San Pedro, CA 90732
11154 Grevillea Ave, Inglewood, CA 90304
1501 Cerritos Dr, Palm Springs, CA 92264
Professional information
Vice President, Global Clinical Affairs At Proteus Biomedical, Inc.
Position:
Vice President, Global Clinical Affairs at Proteus Biomedical, Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Proteus Biomedical, Inc.
-
Vice President, Global Clinical Affairs
Pfizer
2002 - 2009
-
Senior Director, Clinical Development
Tracking And Delivery Confirmation Of Pharmaceutical Products
US Patent:
2013007, Mar 21, 2013
Filed:
May 19, 2011
Appl. No.:
13/698953
Inventors:
Todd Thompson - San Jose CA, US
Lawrence Arne - Palo Alto CA, US
Fataneh Omidvar - Danville CA, US
Yashar Behzadi - San Francisco CA, US
Robert Duck - San Francisco CA, US
Lorenzo Dicarlo - San Francisco CA, US
Gregory Moon - Palo Alto CA, US
Lawrence Arne - Palo Alto CA, US
Fataneh Omidvar - Danville CA, US
Yashar Behzadi - San Francisco CA, US
Robert Duck - San Francisco CA, US
Lorenzo Dicarlo - San Francisco CA, US
Gregory Moon - Palo Alto CA, US
Assignee:
PROTEUS DIGITAL HEALTH, INC. - East Palo Alto CA
International Classification:
G06Q 50/22, H04N 7/18, A61M 3/00, G08C 15/06
US Classification:
705 2, 34087002, 348 77, 604187, 348E07085
Abstract:
A system and method are disclosed that track a deliverable to a user. The system includes an identifier or tag secured to the deliverable, a computer system for interrogating the identifier, and a personal device in communication with the computer system, wherein the personal device is held by the user at the time the user is administered the deliverable to detect the unique identity associated with the identifier device and confirms delivery of the deliverable to the user. The method includes attaching an identifiable tag that produces a unique signature to the deliverable, interrogating the tag at about the time of delivery to the user, and confirming that the user has been administered the deliverable through detecting the identifiable tag.